[
1. Almasi S, Farahani B, Samiei N, Rezaei Y, Mahmoodi H, Qorbani M. Echocardiographic and Electrocardiographic Findings in Patients with Ankylosing Spondylitis without Cardiovascular Risk Factors. J Tehran Heart Cent. 2020 Apr;15(2):43–9.10.18502/jthc.v15i2.4182782546233552193
]Search in Google Scholar
[
2. Valente RLM, Valente JM, de Castro GRW, Zimmermann AF, Fialho SC de MS, Pereira IA. Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation? Rev Bras Reumatol. 2013;53(5):377–81.
]Search in Google Scholar
[
3. Ladehesa-Pineda ML, Arias de la Rosa I, López Medina C, Castro-Villegas MDC, Ábalos-Aguilera MDC, Ortega-Castro R, et al. Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20982837.10.1177/1759720X20982837778031033447266
]Search in Google Scholar
[
4. Heslinga SC, Van den Oever IA, Van Sijl AM, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, et al. Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation. BMC Musculoskelet Disord. 2015;16(1):80.10.1186/s12891-015-0532-3440404725886634
]Search in Google Scholar
[
5. Tran D-MT, Zimmerman LM. Cardiovascular Risk Factors in Young Adults: A Literature Review. J Cardiovasc Nurs. 2015;30(4):298–310.10.1097/JCN.000000000000015024743652
]Search in Google Scholar
[
6. Gooding HC, Gidding SS, Moran AE, Redmond N, Allen NB, Bacha F, et al. Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group. J Am Heart Assoc. 2020 Oct;9(19):e016115.10.1161/JAHA.120.016115779237932993438
]Search in Google Scholar
[
7. George MG, Tong X, Bowman BA. Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults. JAMA Neurol. 2017 Jun;74(6):695–703.10.1001/jamaneurol.2017.0020555966028395017
]Search in Google Scholar
[
8. Rocha E. Cardiovascular risk scores: Usefulness and limitations. Rev Port Cardiol (English Ed. 2016;35(1):15–8.10.1016/j.repc.2015.11.00226755402
]Search in Google Scholar
[
9. Wilkins JT, Lloyd-Jones DM. USPSTF Recommendations for Assessment of Cardiovascular Risk With Nontraditional Risk Factors: Finding the Right Tests for the Right Patients. Vol. 320, JAMA. United States; 2018. p. 242–4.10.1001/jama.2018.934629998347
]Search in Google Scholar
[
10. Liew JW, Ramiro S, Gensler LS. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32(3):369–89.10.1016/j.berh.2019.01.00231171309
]Search in Google Scholar
[
11. Castro AR, Silva SO, Soares SC. The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection. J Pharm Pharm Sci a Publ Can Soc Pharm Sci Soc Can des Sci Pharm. 2018;21(1):496–503.10.18433/jpps2987230496036
]Search in Google Scholar
[
12. Mitchell C, Korcarz CE, Gepner AD, Kaufman JD, Post W, Tracy R, et al. Ultrasound carotid plaque features, cardiovascular disease risk factors and events: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 Sep;276:195–202.10.1016/j.atherosclerosis.2018.06.005743694429970256
]Search in Google Scholar
[
13. González Mazón I, Rueda-Gotor J, Ferraz-Amaro I, Genre F, Corrales A, Calvo Rio V, et al. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients. Semin Arthritis Rheum. 2021 Apr;51(2):395–403.10.1016/j.semarthrit.2021.02.00333607385
]Search in Google Scholar
[
14. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999 Jul;100(1):96–102.10.1161/01.CIR.100.1.96
]Search in Google Scholar
[
15. Rueda-Gotor J, Llorca J, Corrales A, Blanco R, Fuentevilla P, Portilla V, et al. Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. Clin Exp Rheumatol. 2016;34(5):885–92.10.1136/annrheumdis-2016-eular.5779
]Search in Google Scholar
[
16. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017 Jan;76(1):17–28.10.1136/annrheumdis-2016-20977527697765
]Search in Google Scholar
